Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
15.68
-0.01 (-0.06%)
Jun 27, 2025, 3:00 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Traditional Chinese Medicine
6.02B
Log In
Log In
Log In
Log In
Upgrade
Traditional Chinese Medicine Growth
0.88%
Log In
Log In
Log In
Log In
Upgrade
Chemical Preparations
1.31B
Log In
Log In
Log In
Log In
Upgrade
Chemical Preparations Growth
8.62%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Business
894.55M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Business Growth
-26.39%
Log In
Log In
Log In
Log In
Upgrade
Biological Drugs
191.53M
Log In
Log In
Log In
Log In
Upgrade
Biological Drugs Growth
1.06%
Log In
Log In
Log In
Log In
Upgrade
Chemical Raw Materials
51.70M
Log In
Log In
Log In
Log In
Upgrade
Chemical Raw Materials Growth
-9.51%
Log In
Log In
Log In
Log In
Upgrade
Other Business
29.81M
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-20.95%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Industry
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Industry Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
China
8.46B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-1.98%
Log In
Log In
Log In
Log In
Upgrade
Overseas
20.79M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
-11.43%
Log In
Log In
Log In
Log In
Upgrade